Virus-Like Particle Vaccines and Other Vaccine Formulations Against Respiratory Viruses and Protozoan Parasites
A special issue of Vaccines (ISSN 2076-393X). This special issue belongs to the section "Vaccine Adjuvants".
Deadline for manuscript submissions: closed (30 June 2023) | Viewed by 164
Special Issue Editor
2. Medical Research Center for Bioreaction to Reactive Oxygen Species and Biomedical Science Institute, School of Medicine, Graduate School, Kyung Hee University, Seoul 02447, Korea
Interests: virus-like particle vaccines and other vaccine formulations against respiratory virus and parasite infections; vaccine delivery
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Respiratory viruses (influenza virus, respiratory syncytial virus) and protozoan parasites (Plasmodium spp., Toxoplasma gondii, Leishmania spp.) continue to threaten public health worldwide. Although many efforts have been made to develop vaccines, effective vaccines are currently lacking for many of these pathogens. This Special Issue focuses on the development of vaccines based on virus-like particles and other platforms against respiratory viruses and protozoan parasites. We invite the submission of any original research articles and reviews on vaccine studies, and they will be highly appreciated.
Prof. Dr. Fu-Shi Quan
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- vaccine
- vaccine delivery
- respiratory virus
- Plasmodium spp.
- Toxoplasma gondii
- Leishmania spp.
